People

Intranasal cannabinoid developer Therapix Biosciences has announced the appointment of its Chairman of the Board Ascher Shmulewitz as interim CEO. In May 2017, the company said that it was looking for a US-based CEO after Elran Haber stepped down from the role. Therapix licensed an intranasal cannabinoid formulation from Hebrew University’s technology transfer … [Read more...] about Therapix Biosciences appoints Ascher Shmulewitz as interim CEO

AZTherapies, which is developing an inhaled cromolyn/oral ibuprofen combination therapy for the treatment of Alzheimer's disease, has appointed former Pfizer executive Karen Reeves as President and Chief Medical Officer. The company's ALZT-OP1 combination is currently in Phase 3 development. Reeves was most recently VP, Head Global Clinical Submissions Quality and … [Read more...] about Karen Reeves appointed as President and Chief Medical Officer of AZTherapies

Optinose has announced the appointments of Ricci Whitlow as Vice President of Technical Operations, Harry Sacks as VP of Medical Affairs and Corporate Medical Officer, John Peterkins as VP of Market Access, David Fabbri as VP of Sales, and Andrew Muzsi as VP of Marketing. The company's Xhance fluticasone propionate nasal spray for the treatment of nasal polyps … [Read more...] about Optinose announces five appointments

Intranasal etripamil developer Milestone Pharmaceuticals has announced the appointment of Lorenz Muller as Chief Commercial Officer. Muller was most recently VP, Marketing at Exact Sciences Corporation and has previously held positions at Daiichi Sankyo, CV Therapeutics , and Merck. In August 2017, Milestone announced that it had raised $55 million for Phase 3 … [Read more...] about Milestone Pharmaceuticals hires Lorenz Muller as Chief Commercial Officer

Intranasal drug developer Impel NeuroPharma has announced the appointment of former Nivalis Therapeutics leader Jon Congleton as the company’s new President and Chief Executive Officer (CEO). Congleton was most recently President and CEO of Nivalis and had previously served in a number of executive roles at Teva. He succeeds an interim CEO, co-Founder John Hoekman, … [Read more...] about Impel NeuroPharma appoints Jon Congleton as President and CEO

CDMO and device company Hovione has announced the appointment of Frédéric Kahn as VP Marketing and Sales. Kahn most recently served as VP Global Head of Key Account Management at Lonza and previously held executive positions at NextPharma and Gerresheimer. Hovione CEO Guy Villax commented, “We are delighted to welcome Mr. Kahn to Hovione. He is an excellent … [Read more...] about Frédéric Kahn joins Hovione as VP of Marketing and Sales

Former Medicon Valley Inhalation Consortium (MVIC) CEO Ola Nerbrink has joined PreciseInhale maker Inhalation Sciences (ISAB) as Senior Sales Advisor, the company said. Nerbrink, who stepped down as MVIC CEO earlier this year, founded Respiron Consulting in 2009 after having worked at AstraZeneca and Novo Nordisk. The PreciseInhale system generates dry powder … [Read more...] about Ola Nerbrink joins Inhalation Sciences as Senior Sales Advisor

Device developer Coalesce Product Development has announced the appointments of Stephen Eason as Strategic Advisor and IP Consultant, and Mike Newton as Engineering Consultant. Both men have extensive experience in the development of OINDP devices. Eason led development of the Aspirair dry powder inhaler while at Cambridge Consultants and joined Vectura as Senior … [Read more...] about Coalesce Product Development hires two former Vectura OINDP device experts

Theravance Biopharma has announced the appointment of former Roche Partnering VP Shehnaaz Suliman as Senior VP, Corporate Development and Strategy. Theravance Biopharma Chairman and CEO Rick E. Winningham commented, "We are thrilled to add an individual of Dr. Suliman's impressive accomplishments, leadership and energy to our senior team. Her successes in the … [Read more...] about Therevance Biopharma appoints Shehnaaz Suliman as Senior VP, Corporate Development and Strategy

Inhaler testing instrument company Copley Scientific has announced the appointment of Anna Sipitanou as Business Development Manager. Sipitanou was most recently Business Development Manager at Cellomatics Biosciences, and her prior experience includes development of IVIVC models as a research associate at Nottingham University. Copley Scientific Sales Director … [Read more...] about Anna Sipitanou joins Copley Scientific as Business Development Manager